XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF SERIES A REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Series A Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Noncontrolling Interests in Operating Subsidiaries
Treasury Stock, Common
Beginning balance (in shares) at Dec. 31, 2022   350,000          
Beginning balance at Dec. 31, 2022   $ 19,924          
Increase (Decrease) in Temporary Equity [Roll Forward]              
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value   $ 1,554          
Ending balance (in shares) at Mar. 31, 2023   350,000          
Ending balance at Mar. 31, 2023   $ 21,478          
Beginning balance (in shares) at Dec. 31, 2022     43,484,867        
Beginning balance at Dec. 31, 2022 $ 269,322   $ 43 $ 663,284 $ (306,789) $ 11,042 $ (98,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries 9,447       9,447 0  
Accretion of Series A Redeemable Convertible Preferred Stock to redemption value (1,554)     (1,554)      
Dividend on Series A Redeemable Convertible Preferred Stock (700)     (700)      
Issuance of common stock from the Rights Offering, Shares     15,068,753        
Issuance of common stock from the Rights Offering 79,111   $ 15 79,096      
Issuance of common stock for vesting of restricted stock units (in shares)     110,541        
Issuance of common stock for unvested restricted stock awards, net of forfeitures (in shares)     (17,500)        
Shares withheld related to net share settlement of share-based awards (in shares)     (94,863)        
Shares withheld related to net share settlement of share-based awards (416)     (416)      
Compensation expense for share-based awards 477     477      
Ending balance (in shares) at Mar. 31, 2023     58,551,798        
Ending balance at Mar. 31, 2023 355,687   $ 58 740,187 (297,342) 11,042 (98,258)
Beginning balance (in shares) at Dec. 31, 2023   0          
Beginning balance at Dec. 31, 2023   $ 0          
Ending balance (in shares) at Mar. 31, 2024   0          
Ending balance at Mar. 31, 2024   $ 0          
Beginning balance (in shares) at Dec. 31, 2023     99,895,473        
Beginning balance at Dec. 31, 2023 589,609   $ 100 906,153 (239,729) 21,343 (98,258)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income including noncontrolling interests in subsidiaries (189)       (186) (3)  
Issuance of common stock for vesting of restricted stock units (in shares)     275,244        
Shares withheld related to net share settlement of share-based awards (in shares)     (148,766)        
Shares withheld related to net share settlement of share-based awards (674)     (674)      
Compensation expense for share-based awards 858     858      
Ending balance (in shares) at Mar. 31, 2024     100,021,951        
Ending balance at Mar. 31, 2024 $ 589,604   $ 100 $ 906,337 $ (239,915) $ 21,340 $ (98,258)